{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T14:50:59Z","timestamp":1789915859479,"version":"4.0.1"},"reference-count":71,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Brazilian agencies FAPESP","award":["2011\/21433-7"],"award-info":[{"award-number":["2011\/21433-7"]}]},{"name":"Brazilian agencies FAPESP","award":["2012\/12247-8"],"award-info":[{"award-number":["2012\/12247-8"]}]},{"name":"Brazilian agencies FAPESP","award":["2013\/05099-5"],"award-info":[{"award-number":["2013\/05099-5"]}]},{"name":"Brazilian agencies FAPESP","award":["301239\/2012-6"],"award-info":[{"award-number":["301239\/2012-6"]}]},{"name":"Brazilian Synchrotron Light Laboratory for SAXS facilities"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.phrs.2016.05.032","type":"journal-article","created":{"date-parts":[[2016,6,3]],"date-time":"2016-06-03T04:03:52Z","timestamp":1464926632000},"page":"102-112","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"special_numbering":"C","title":["Enhancement of chlorpromazine antitumor activity by Pluronics F127\/L81 nanostructured system against human multidrug resistant leukemia"],"prefix":"10.1016","volume":"111","author":[{"given":"Joyce C de","family":"Mello","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivian WR","family":"Moraes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina M.","family":"Watashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deyse C","family":"da Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leide P","family":"Cavalcanti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margareth KKD","family":"Franco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabiano","family":"Yokaichiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele R","family":"de Araujo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1277-0224","authenticated-orcid":false,"given":"Tiago","family":"Rodrigues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl. 2","key":"10.1016\/j.phrs.2016.05.032_bib0005","doi-asserted-by":"crossref","first-page":"S107","DOI":"10.1007\/s00277-015-2325-z","article-title":"Natural course and biology of CML","volume":"94","author":"Chereda","year":"2015","journal-title":"Ann. Hematol."},{"issue":"8","key":"10.1016\/j.phrs.2016.05.032_bib0010","doi-asserted-by":"crossref","first-page":"2838","DOI":"10.1158\/0008-5472.CAN-10-4600","article-title":"A multicellular basis for the origination of blast crisis in chronic myeloid leukemia","volume":"71","author":"Sachs","year":"2011","journal-title":"Cancer Res."},{"issue":"6","key":"10.1016\/j.phrs.2016.05.032_bib0015","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20130067","article-title":"Multidrug resistance in chronic myeloid leukaemia: how much can we learn from MDR-CML cell lines?","volume":"33","author":"Rumjanek","year":"2013","journal-title":"Biosci. Rep."},{"issue":"1-2","key":"10.1016\/j.phrs.2016.05.032_bib0020","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s11010-013-1761-0","article-title":"Characterization of a multidrug-resistant chronic myeloid leukemia cell line presenting multiple resistance mechanisms","volume":"383","author":"Daflon-Yunes","year":"2013","journal-title":"Mol. Cellular Biochem."},{"issue":"9","key":"10.1016\/j.phrs.2016.05.032_bib0025","doi-asserted-by":"crossref","first-page":"2624","DOI":"10.1021\/bm300848c","article-title":"Nature of interactions between PEO-PPO-PEO triblock copolymers and lipid membranes: (II) role of hydration dynamics revealed by dynamic nuclear polarization","volume":"13","author":"Cheng","year":"2012","journal-title":"Biomacromolecules"},{"issue":"10","key":"10.1016\/j.phrs.2016.05.032_bib0030","doi-asserted-by":"crossref","first-page":"4042","DOI":"10.1021\/bi048373q","article-title":"Relationship between the structure of amphiphilic copolymers and their ability to disturb lipid bilayers","volume":"44","author":"Demina","year":"2005","journal-title":"Biochemistry"},{"issue":"2","key":"10.1016\/j.phrs.2016.05.032_bib0035","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1177\/0883911506063207","article-title":"Perspectives on: PEO-PPO-PEO triblock copolymers and their biomedical applications","volume":"21","author":"Fusco","year":"2006","journal-title":"J. Bioact. Compat. Polym."},{"issue":"9","key":"10.1016\/j.phrs.2016.05.032_bib0040","doi-asserted-by":"crossref","first-page":"3305","DOI":"10.1021\/ma991634x","article-title":"Relationship between pluronic block copolymer structure, critical micellization concentration and partitioning coefficients of low molecular mass solutes","volume":"33","author":"Kozlov","year":"2000","journal-title":"Macromolecules"},{"key":"10.1016\/j.phrs.2016.05.032_bib0045","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1080\/10915810802244595","volume":"27","author":"Singh-Joy","year":"2008","journal-title":"Int. J. Toxicol."},{"issue":"6","key":"10.1016\/j.phrs.2016.05.032_bib0050","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1097\/PRS.0b013e3181ccdbef","article-title":"Poloxamer 188 protects against ischemia-Reperfusion injury in a murine hind-Limb model","volume":"125","author":"Murphy","year":"2010","journal-title":"Plast. Reconstr. Surg."},{"issue":"11","key":"10.1016\/j.phrs.2016.05.032_bib0055","doi-asserted-by":"crossref","first-page":"2894","DOI":"10.1016\/j.biomaterials.2010.12.039","article-title":"Multifunctional Pluronic P123\/F127 mixed polymeric micelles loaded with paclitaxel for the treatment of multidrug resistant tumors","volume":"32","author":"Zhang","year":"2011","journal-title":"Biomaterials"},{"issue":"36","key":"10.1016\/j.phrs.2016.05.032_bib0060","doi-asserted-by":"crossref","first-page":"4669","DOI":"10.2174\/138161206779026245","article-title":"Polymeric micelles for drug delivery","volume":"12","author":"Croy","year":"2006","journal-title":"Curr. Pharm. Des."},{"issue":"8","key":"10.1016\/j.phrs.2016.05.032_bib0065","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.2174\/138945011795906615","article-title":"PEO-PPO block copolymers for passive micellar targeting and overcoming multidrug resistance in cancer therapy","volume":"12","author":"Alvarez-Lorenzo","year":"2011","journal-title":"Curr. Drug Targets"},{"issue":"2","key":"10.1016\/j.phrs.2016.05.032_bib0070","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jconrel.2008.04.013","article-title":"Pluronic block copolymers: evolution of drug delivery concept from inert nanocarriers to biological response modifiers","volume":"130","author":"Batrakova","year":"2008","journal-title":"J. Control. Release"},{"issue":"6","key":"10.1016\/j.phrs.2016.05.032_bib0075","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/j.cell.2012.03.049","article-title":"Identification of drugs including a dopamine receptor antagonist that selectively target cancer stem cells","volume":"149","author":"Sachlos","year":"2012","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.phrs.2016.05.032_bib0080","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/S1734-1140(12)70726-0","article-title":"Chemical structure of phenothiazines and their biological activity","volume":"64","author":"Jaszczyszyn","year":"2012","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.phrs.2016.05.032_bib0085","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2011.62","article-title":"Chemosensitization by phenothiazines in human lung cancer cells: impaired resolution of gamma H2AX and increased oxidative stress elicit apoptosis associated with lysosomal expansion and intense vacuolation","volume":"2","author":"Zong","year":"2011","journal-title":"Cell. Death. Dis."},{"key":"10.1016\/j.phrs.2016.05.032_bib0090","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.tox.2015.02.004","article-title":"Cytotoxicity of phenothiazine derivatives associated with mitochondrial dysfunction: a structure-activity investigation","volume":"330","author":"de Faria","year":"2015","journal-title":"Toxicology"},{"issue":"4","key":"10.1016\/j.phrs.2016.05.032_bib0095","first-page":"495","article-title":"Fifty years chlorpromazine: a historical perspective","volume":"3","author":"Ban","year":"2007","journal-title":"Neuropsychiatr. Dis. Treat."},{"issue":"4","key":"10.1016\/j.phrs.2016.05.032_bib0100","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.jpainsymman.2009.08.010","article-title":"A systematic review of the treatment of nausea and\/or vomiting in cancer unrelated to chemotherapy or radiation","volume":"39","author":"Davis","year":"2010","journal-title":"J. Pain Symptom Manag."},{"issue":"20","key":"10.1016\/j.phrs.2016.05.032_bib0105","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1056\/NEJM195411112512007","article-title":"Chlorpromazine in patients with nausea and vomiting due to advanced cancer","volume":"251","author":"Homburger","year":"1954","journal-title":"New Engl. J. Med."},{"issue":"4","key":"10.1016\/j.phrs.2016.05.032_bib0110","doi-asserted-by":"crossref","first-page":"433","DOI":"10.18388\/abp.2011_2209","article-title":"Interaction of phenothiazines, stilbenes and flavonoids with multidrug resistance-associated transporters P-glycoprotein and MRP1","volume":"58","author":"Wesolowska","year":"2011","journal-title":"Acta Biochim. Pol."},{"issue":"6","key":"10.1016\/j.phrs.2016.05.032_bib0115","doi-asserted-by":"crossref","DOI":"10.1002\/jbm.820060609","article-title":"Artificial skin .I. Preparation and Properties of Pluronic F-127 Gels for Treatment of Burns","volume":"6","author":"Schmolka","year":"1972","journal-title":"J. Biomed. Mater. Res."},{"issue":"2","key":"10.1016\/j.phrs.2016.05.032_bib0120","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.colsurfb.2007.12.009","article-title":"Effect of pharmaceuticals on thermoreversible gelation of PEO-PPO-PEO copolymers","volume":"63","author":"Sharma","year":"2008","journal-title":"Colloid Surf. B"},{"issue":"45","key":"10.1016\/j.phrs.2016.05.032_bib0125","doi-asserted-by":"crossref","first-page":"13689","DOI":"10.1021\/la503021c","article-title":"Pluronics F-127\/L-81 binary hydrogels as drug-Delivery systems: influence of physicochemical aspects on release kinetics and cytotoxicity","volume":"30","author":"Oshiro","year":"2014","journal-title":"Langmuir"},{"issue":"1\u2fff2","key":"10.1016\/j.phrs.2016.05.032_bib0130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0927-7757(94)03028-X","article-title":"Poly(Ethylene oxide)-Poly(Propylene oxide)-Poly(Ethylene oxide) block-Copolymer surfactants in aqueous-Solutions and at interfaces \u2fff thermodynamics, structure, dynamics and modeling","volume":"96","author":"Alexandridis","year":"1995","journal-title":"Colloid Surf. A"},{"issue":"3","key":"10.1016\/j.phrs.2016.05.032_bib0135","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1182\/blood.V45.3.321.321","article-title":"Human chronic myelogenous leukemia cell-Line with positive philadelphia chromosome","volume":"45","author":"Lozzio","year":"1975","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.phrs.2016.05.032_bib0140","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1590\/S0001-37652001000100007","article-title":"Multidrug resistance in tumour cells: characterisation of the multidrug resistant cell line K562-Lucena 1","volume":"73","author":"Rumjanek","year":"2001","journal-title":"An. Acad. Bras. Cienc."},{"issue":"5","key":"10.1016\/j.phrs.2016.05.032_bib0145","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1021\/jp208902a","article-title":"Effects of interaction of ionic and nonionic surfactants on self-Assembly of PEO-PPO-PEO triblock copolymer in aqueous solution","volume":"116","author":"Nambam","year":"2012","journal-title":"J. Phys. Chem. B"},{"issue":"3","key":"10.1016\/j.phrs.2016.05.032_bib0150","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.3390\/ijms12031684","article-title":"Docetaxel-Loaded pluronic P123 polymeric micelles: in vitro and in vivo evaluation","volume":"12","author":"Liu","year":"2011","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.phrs.2016.05.032_bib0155","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jcis.2014.07.045","article-title":"Preparation optimization, characterization and cytotoxicity in vitro of Baicalin-loaded mixed micelles","volume":"434","author":"Zhang","year":"2014","journal-title":"J. Colloid Interface Sci."},{"key":"10.1016\/j.phrs.2016.05.032_bib0160","article-title":"Dual-functional c(RGDyK)-decorated Pluronic micelles designed for antiangiogenesis and the treatment of drug-resistant tumor","volume":"10","author":"Chen","year":"2015","journal-title":"Int. J. Nanomed."},{"issue":"8","key":"10.1016\/j.phrs.2016.05.032_bib0165","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1007\/s11095-010-0147-1","article-title":"Novel mixed polymeric micelles for enhancing delivery of anticancer drug and overcoming multidrug resistance in tumor cell lines simultaneously","volume":"27","author":"Li","year":"2010","journal-title":"Pharm. Res-Dordr"},{"issue":"9","key":"10.1016\/j.phrs.2016.05.032_bib0170","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.2174\/138945006778226660","article-title":"Phenothiazines and structurally related compounds as modulators of cancer multidrug resistance","volume":"7","author":"Tsakovska","year":"2006","journal-title":"Curr. Drug Targets"},{"issue":"6","key":"10.1016\/j.phrs.2016.05.032_bib0175","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/0277-5379(84)90219-0","article-title":"Correlation between potency of calmodulin inhibitors and effects on cellular-Levels and cyto-Toxic activity of doxorubicin (Adriamycin) in resistant P388 mouse leukemia-Cells","volume":"20","author":"Ganapathi","year":"1984","journal-title":"Eur. J. Cancer Clin. Oncol."},{"issue":"10","key":"10.1016\/j.phrs.2016.05.032_bib0180","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1023\/A:1026179132599","article-title":"Sensitization of cells overexpressing multidrug-resistant proteins by Pluronic P85","volume":"20","author":"Batrakova","year":"2003","journal-title":"Pharm. Res-Dordr"},{"issue":"5","key":"10.1016\/j.phrs.2016.05.032_bib0185","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1200\/JCO.1988.6.5.880","article-title":"Clinical modulation of doxorubicin resistance by the calmodulin-Inhibitor, trifluoperazine \u2fff a phase-I\/Ii trial","volume":"6","author":"Miller","year":"1988","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.phrs.2016.05.032_bib0190","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/B978-0-12-385524-4.00002-7","article-title":"The essential role of evasion from cell death in cancer","volume":"111","author":"Kelly","year":"2011","journal-title":"Adv. Cancer Res."},{"issue":"10","key":"10.1016\/j.phrs.2016.05.032_bib0195","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1038\/nrc3599","article-title":"Cancer drug resistance: an evolving paradigm","volume":"13","author":"Holohan","year":"2013","journal-title":"Nat. Rev. Cancer"},{"issue":"13-14","key":"10.1016\/j.phrs.2016.05.032_bib0200","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1016\/j.addr.2013.09.019","article-title":"Nanomedicine therapeutic approaches to overcome cancer drug resistance","volume":"65","author":"Markman","year":"2013","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"64","key":"10.1016\/j.phrs.2016.05.032_bib0205","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3001385","article-title":"Improving drug potency and efficacy by nanocarrier-Mediated subcellular targeting","volume":"3","author":"Murakami","year":"2011","journal-title":"Sci. Transl. Med."},{"issue":"3","key":"10.1016\/j.phrs.2016.05.032_bib0210","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.jconrel.2011.12.012","article-title":"Polymeric micelles drug delivery system in oncology","volume":"159","author":"Gong","year":"2012","journal-title":"J. Control. Release"},{"issue":"3","key":"10.1016\/j.phrs.2016.05.032_bib0215","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.jconrel.2010.08.021","article-title":"Paclitaxel-loaded Pluronic nanoparticles formed by a temperature-induced phase transition for cancer therapy","volume":"148","author":"Oh","year":"2010","journal-title":"J. Control. Release"},{"issue":"2","key":"10.1016\/j.phrs.2016.05.032_bib0220","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.ijpharm.2011.09.009","article-title":"Molecular mechanism study of chemosensitization of doxorubicin-resistant human myelogenous leukemia cells induced by a composite polymer micelle","volume":"420","author":"Han","year":"2011","journal-title":"Int. J. Pharm."},{"issue":"3","key":"10.1016\/j.phrs.2016.05.032_bib0225","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.jconrel.2010.01.004","article-title":"Effects of pluronic and doxorubicin on drug uptake, cellular metabolism, apoptosis and tumor inhibition in animal models of MDR cancers","volume":"143","author":"Batrakova","year":"2010","journal-title":"J. Control. Release"},{"issue":"1","key":"10.1016\/j.phrs.2016.05.032_bib0230","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jconrel.2009.09.026","article-title":"Differential metabolic responses to pluronic in MDR and non-MDR cells: a novel pathway for chemosensitization of drug resistant cancers","volume":"142","author":"Alakhova","year":"2010","journal-title":"J. Control. Release"},{"issue":"2","key":"10.1016\/j.phrs.2016.05.032_bib0235","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.jcis.2008.09.029","article-title":"Mechanisms of micellization and rheology of PEO-PPO-PEO triblock copolymers with various architectures","volume":"328","author":"Trong","year":"2008","journal-title":"J. Colloid Interface Sci."},{"issue":"13","key":"10.1016\/j.phrs.2016.05.032_bib0240","doi-asserted-by":"crossref","first-page":"4350","DOI":"10.1021\/la304836e","article-title":"Encapsulation of hydrophobic drugs in pluronic F127 micelles: effects of drug hydrophobicity, solution temperature, and pH","volume":"29","author":"Basak","year":"2013","journal-title":"Langmuir"},{"issue":"1","key":"10.1016\/j.phrs.2016.05.032_bib0245","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejpb.2007.08.001","article-title":"Nanoparticles for drug delivery: the need for precision in reporting particle size parameters","volume":"69","author":"Gaumet","year":"2008","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"9","key":"10.1016\/j.phrs.2016.05.032_bib0250","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1002\/jps.10190","article-title":"Distribution, metabolism, and excretion of a novel surface-active agent, purified poloxamer 188, in rats, dogs, and humans","volume":"91","author":"Grindel","year":"2002","journal-title":"J. Pharm. Sci."},{"issue":"1","key":"10.1016\/j.phrs.2016.05.032_bib0255","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1107\/S0021889899013369","article-title":"Formation of homogeneous gel-like phases by mixed triblock copolymer micelles in aqueous solution: FCC to BCC phase transition","volume":"33","author":"Liu","year":"2000","journal-title":"J. Appl. Crystallogr."},{"issue":"1-3","key":"10.1016\/j.phrs.2016.05.032_bib0260","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.bpc.2010.08.001","article-title":"pH-dependent interaction of psychotropic drug with glycerophospholipid monolayers studied by the Langmuir technique","volume":"152","author":"Steinkopf","year":"2010","journal-title":"Biophys. Chem."},{"issue":"1-2","key":"10.1016\/j.phrs.2016.05.032_bib0265","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.bpc.2007.07.001","article-title":"Phase separation is induced by phenothiazine derivatives in phospholipid\/sphingomyelin\/cholesteroI mixtures containing low levels of cholesterol and sphingomyelin","volume":"130","author":"Hendrich","year":"2007","journal-title":"Biophys. Chem."},{"issue":"3","key":"10.1016\/j.phrs.2016.05.032_bib0270","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.taap.2004.06.017","article-title":"Modulation of P-glycoprotein-mediated multidrug resistance in K562 leukemic cells by indole-3-carbinol","volume":"202","author":"Arora","year":"2005","journal-title":"Toxicol. Appl. Pharm."},{"issue":"1","key":"10.1016\/j.phrs.2016.05.032_bib0275","doi-asserted-by":"crossref","first-page":"85","DOI":"10.2133\/dmpk.DMPK-11-RV-098","article-title":"Functional significance of genetic polymorphisms in P-glycoprotein (MDR1, ABCB1) and Breast cancer resistance protein (BCRP, ABCG2)","volume":"27","author":"Ieiri","year":"2012","journal-title":"Drug Metab. Pharmacokinet."},{"key":"10.1016\/j.phrs.2016.05.032_bib0280","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1146\/annurev.pharmtox.39.1.361","article-title":"Biochemical, cellular, and pharmacological aspects of the multidrug transporter","volume":"39","author":"Ambudkar","year":"1999","journal-title":"Annu. Rev. Pharmacol."},{"issue":"9","key":"10.1016\/j.phrs.2016.05.032_bib0285","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.2174\/138945006778226570","article-title":"Interactions of phenothiazines with lipid bilayer and their role in multidrug resistance reversal","volume":"7","author":"Michalak","year":"2006","journal-title":"Curr. Drug Targets"},{"issue":"6","key":"10.1016\/j.phrs.2016.05.032_bib0290","doi-asserted-by":"crossref","first-page":"685","DOI":"10.2174\/0929867013373138","article-title":"Structure-activity relationships of multidrug resistance reversers","volume":"8","author":"Wiese","year":"2001","journal-title":"Curr. Med. Chem."},{"issue":"1","key":"10.1016\/j.phrs.2016.05.032_bib0295","first-page":"105","article-title":"Structural features determining activity of phenothiazines and related drugs for inhibition of cell-Growth and reversal of multidrug resistance","volume":"35","author":"Ford","year":"1989","journal-title":"Mol. Pharmacol."},{"issue":"48","key":"10.1016\/j.phrs.2016.05.032_bib0300","doi-asserted-by":"crossref","first-page":"14927","DOI":"10.1021\/bi0018786","article-title":"Intrinsic fluorescence of the P-glycoprotein multidrug transporter: sensitivity of tryptophan residues to binding of drugs and nucleotides","volume":"39","author":"Liu","year":"2000","journal-title":"Biochemistry"},{"issue":"2","key":"10.1016\/j.phrs.2016.05.032_bib0305","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0925-4439(97)00026-4","article-title":"Structure-activity relationships of P-glycoprotein interacting drugs: kinetic characterization of their effects on ATPase activity","volume":"1361","author":"Litman","year":"1997","journal-title":"BBA-Mol. Basis Dis."},{"issue":"4","key":"10.1016\/j.phrs.2016.05.032_bib0310","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.ejps.2006.03.002","article-title":"Suppression of P-glycoprotein expression by antipsychotics trifluoperazine in adriamycin-resistant L1210 mouse leukemia cells","volume":"28","author":"Shin","year":"2006","journal-title":"Eur. J. Pharm. Sci."},{"issue":"13","key":"10.1016\/j.phrs.2016.05.032_bib0315","doi-asserted-by":"crossref","first-page":"6474","DOI":"10.1016\/j.bmc.2008.05.040","article-title":"Multidrug resistance reverting activity and antitumor profile of new phenothiazine derivatives","volume":"16","author":"Bisi","year":"2008","journal-title":"Bioorgan. Med. Chem."},{"issue":"3","key":"10.1016\/j.phrs.2016.05.032_bib0320","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1046\/j.1365-2710.2003.00487.x","article-title":"Structure-activity relationship: analyses of p-glycoprotein substrates and inhibitors","volume":"28","author":"Wang","year":"2003","journal-title":"J. Clin. Pharm. Ther."},{"issue":"8","key":"10.1016\/j.phrs.2016.05.032_bib0325","first-page":"3696","article-title":"Enhancement of sensitivity to adriamycin in resistant P388-Leukemia by the calmodulin inhibitor trifluoperazine","volume":"43","author":"Ganapathi","year":"1983","journal-title":"Cancer Res."},{"issue":"12","key":"10.1016\/j.phrs.2016.05.032_bib0330","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1054\/bjoc.2001.2165","article-title":"Mechanism of sensitization of MDR cancer cells by Pluronic block copolymers: selective energy depletion","volume":"85","author":"Batrakova","year":"2001","journal-title":"Br. J. Cancer"},{"issue":"1-2","key":"10.1016\/j.phrs.2016.05.032_bib0335","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2007.08.021","article-title":"Effect of excipients on breast cancer resistance protein substrate uptake activity","volume":"124","author":"Yamagata","year":"2007","journal-title":"J. Control. Release"},{"issue":"12","key":"10.1016\/j.phrs.2016.05.032_bib0340","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.1007\/s11095-004-7675-5","article-title":"Effect of pluronic P85 on ATPase activity of drug efflux transporters","volume":"21","author":"Batrakova","year":"2004","journal-title":"Pharm. Res."},{"issue":"2","key":"10.1016\/j.phrs.2016.05.032_bib0345","first-page":"483","article-title":"Mechanism of pluronic effect on P-glycoprotein efflux system in blood-brain barrier: contributions of energy depletion and membrane fluidization","volume":"299","author":"Batrakova","year":"2001","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"3","key":"10.1016\/j.phrs.2016.05.032_bib0350","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1016\/j.biomaterials.2013.10.049","article-title":"Co-delivery of thioridazine and doxorubicin using polymeric micelles for targeting both cancer cells and cancer stem cells","volume":"35","author":"Ke","year":"2014","journal-title":"Biomaterials"},{"issue":"1","key":"10.1016\/j.phrs.2016.05.032_bib0355","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s002800050449","article-title":"Trifluoperazine as a modulator of multidrug resistance in refractory breast cancer","volume":"38","author":"Murren","year":"1996","journal-title":"Cancer Chemoth. Pharm."}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661816305266?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661816305266?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,21]],"date-time":"2020-09-21T15:24:58Z","timestamp":1600701898000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661816305266"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":71,"alternative-id":["S1043661816305266"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2016.05.032","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Enhancement of chlorpromazine antitumor activity by Pluronics F127\/L81 nanostructured system against human multidrug resistant leukemia","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2016.05.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}